Skip to content Skip to footer

ISSN 1933-0863 (PRINT) ISSN 1933-0871 (ONLINE)

Menu
Menu

Home

Main menu

Trending

Latest Issue

Articles
Urine C-reactive protein content and non-invasive molecular grading of renal cell carcinoma
Introduction Renal cell carcinoma (RCC) accounts for 4.2% of adult malignancies and is the 10th leading cause of cancer deaths in the United States.1 In the United States in 2024, more than 81,000 new cases were diagnosed and more than 14,300 died, due…
March 16, 2019
Articles
Practice-Ready Molecular Imaging in Renal Cell Carcinoma
Abstract : BACKGROUND: Renal cell carcinoma (RCC) is the most common kidney malignancy, often associated with poor prognosis due to late-stage diagnosis and metastasis. Recent research has identified PIWI-interacting RNAs (piRNAs) and PIWI-like proteins as potential biomarkers and therapeutic targets in cancer,…
February 20, 2026
Articles
The New Frontier: Advancements in Kidney Cancer Treatment
Thomas E. Hutson, DO, PharmD Texas Tech University Health Science Center School of Medicine Lubbock, Texas 79415 Correspondence to: Thomas Hutson, DO, PharmD Dear colleagues, The landscape of kidney cancer treatment is in a state of rapid and thrilling evolution. As editors,…
February 20, 2026
Articles
Kidney Cancer Summary from ASCO 2025: Therapies, Biomarkers, and Beyond
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial Citation: Zhou A, et al. Lancet Oncology. 2025 Sep;26(9):1145–1157. Methods: ETER100 was a multicentre, randomised, open-label, phase 3 trial at 37 sites in China. Patients aged…
February 20, 2026
Articles
The Future of RCC Treatment
Thomas E. Hutson, DO, PharmD Texas Tech University Health Science Center School of Medicine Lubbock, Texas 79415 Correspondence to: Thomas Hutson, DO, PharmD The Kidney Cancer Journal is pleased to receive and review the expert consensus manuscript stemming from the IKCSEU24 Think…
February 21, 2026

Current Trends

Articles
Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond: Building on Lessons Learned From the Pandemic | Kidney Cancer Journal KCJ Roundtable Monograph Open Access Changes, Challenges and Opportunities in Cancer Care During the COVID-19 Era and Beyond: Building…
AROUND THE CORNER:Top Developments in Genitourinary Cancer Therapeutics
Articles
The third quarter of 2026 was defined less by new readouts than by regulatory follow-through. Data from ASCO GU and the ASCO Annual Meeting turned into FDA approvals in muscle-invasive bladder cancer and metastatic hormone-sensitive prostate cancer, and biomarker-selected strategies moved firmly…
JOURNAL CLUB
Articles Journal Club Latest Issue Latest Updates
Journal Club selections are curated by the Kidney Cancer Journal editorial team based on clinical significance, study design rigor, and potential impact on practice. Full-text access available via PubMed and respective journal platforms. Belzutifan plus lenvatinib versus cabozantinib in patients with previously…

Explore Our New Articles